New pathogenic mutation of chorea-acanthocytosis.
Garrido-Fernández A, Santos-Lasaosa S, Bellosta-Diago E, Sáchez-Valiente S.
Neurologia (Engl Ed). 2020 Mar;35(2):73-74. doi: 10.1016/j.nrl.2018.03.012. Epub 2018 May 8.
Acanthocytosis and neurological disorders.
Stevenson VL, Hardie RJ.
J Neurol. 2001 Feb;248(2):87-94. doi: 10.1007/s004150170241.
Acanthocytosis in an alectinib-treated patient.
Legland Ép Dejean AM, Plantamura J, Arnoux I, Paleiron N, Loosveld M, Buono Ép Foucher B.
Br J Haematol. 2022 Apr;197(2):131. doi: 10.1111/bjh.18020. Epub 2022 Feb 7.
Progress in the Diagnosis and Management of Chorea-acanthocytosis.
Liu Y, Liu ZY, Wan XH, Guo Y.
Chin Med Sci J. 2018 Mar 30;33(1):53-59. doi: 10.24920/21802.
Acanthocytosis.
Craandijk A, Houtsmuller AJ, Junge J, Aan de Kerk AL.
Ophthalmologica. 1968;156(1):91. doi: 10.1159/000305376.
Acanthocytosis: a key feature for the diagnosis of abetalipoproteinemia.
Lausch E, Yoshimi A.
Blood. 2023 Jun 29;141(26):3231. doi: 10.1182/blood.2023020260.
Acanthocytosis and neurological impairment--a review.
Hardie RJ.
Q J Med. 1989 Apr;71(264):291-306.
Marked Acanthocytosis Associated With Klipple Trenaunay Syndrom.
Ali SM, Raza N, Aftab E, Mohammad MF.
J Ayub Med Coll Abbottabad. 2023 Feb-Mar;35(1):182-185. doi: 10.55519/JAMC-01-11307.
[ACANTHOCYTOSIS].
STOECKER JP.
Ned Tijdschr Geneeskd. 1964 Sep 19;108:1830-1.
Abetalipoproteinemia.
Kayden HJ.
Annu Rev Med. 1972;23:285-96. doi: 10.1146/annurev.me.23.020172.001441.
